• Explore /
  • Poster
  • / Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08.

Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08.

Abstract Poster

Authors

Roger Von Moos

Roger Von Moos

Kantonsspital Graubünden, Chur, Switzerland

Roger Von Moos , Dieter Koeberle , Sabina Schacher , Stefanie Hayoz , Ralph C. Winterhalder , Arnaud Roth , Gyorgy Bodoky , Panagiotis Samaras , Martin D Berger , Daniel Rauch , Piercarlo Saletti , Ludwig Plasswilm , Peter Thum , Urs R. Meier , Pu Yan , Paola Izzo , Dirk Klingbiel , Daniela Baertschi , Kathrin Zaugg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00869570

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3531)

DOI

10.1200/jco.2014.32.15_suppl.3531

Abstract #

3531

Poster Bd #

20

Abstract Disclosures

Similar Posters

First Author: Roger Von Moos

First Author: D. Helbling

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.

Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.

First Author: Meng Wang

First Author: Jun Watanabe